Clinical Trial Update: Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial is evaluating the efficacy and safety of LV232 capsules for major depressive disorder. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LV232 capsules (LV232)

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: MDD | Phase 2 | Status: RECRUITING